Crescita Therapeutics Inc.
CRRTF
$0.3901
-$0.0013-0.33%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.01M | -2.21M | -1.74M | -1.48M | -498.90K |
| Total Depreciation and Amortization | 1.02M | 1.07M | 1.12M | 1.12M | 1.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 384.70K | 338.60K | 505.80K | 702.60K | 149.30K |
| Change in Net Operating Assets | 1.41M | 1.38M | 351.30K | 1.20M | -668.40K |
| Cash from Operations | 799.20K | 581.50K | 242.10K | 1.54M | 97.20K |
| Capital Expenditure | -1.35M | -764.60K | -98.10K | -98.10K | -30.50K |
| Sale of Property, Plant, and Equipment | 57.20K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -44.90K |
| Cash from Investing | -1.30M | -764.60K | -98.10K | -98.10K | -75.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -433.00K | -426.00K | -417.00K | -408.00K | -402.00K |
| Issuance of Common Stock | 0.00 | 19.00K | 19.00K | 19.00K | 19.00K |
| Repurchase of Common Stock | -396.00K | -519.00K | -471.00K | -393.00K | -312.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | -50.00K | -50.00K | -- | -50.00K |
| Cash from Financing | -646.50K | -721.70K | -681.40K | -579.60K | -552.80K |
| Foreign Exchange rate Adjustments | -15.40K | 13.50K | -11.00K | -10.30K | 5.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.16M | -891.30K | -548.50K | 849.20K | -525.10K |
